메뉴 건너뛰기




Volumn , Issue , 2011, Pages 330-345

Alterations in Nutrition and Body Mass in Heart Failure

Author keywords

[No Author keywords available]

Indexed keywords


EID: 84884453963     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-5895-3.10021-X     Document Type: Chapter
Times cited : (3)

References (234)
  • 1
    • 36248953983 scopus 로고    scopus 로고
    • American Heart Association.Heart disease and stroke statistics
    • American Heart Association, Dallas
    • American Heart Association.Heart disease and stroke statistics Update 2005, American Heart Association, Dallas.
    • (2005) Update
  • 2
    • 17944374924 scopus 로고    scopus 로고
    • Guidelines for the diagnosis and treatment of chronic heart failure
    • Remme W.J., Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001, 22:1527-1560.
    • (2001) Eur Heart J , vol.22 , pp. 1527-1560
    • Remme, W.J.1    Swedberg, K.2
  • 3
    • 0034820506 scopus 로고    scopus 로고
    • More "malignant" than cancer? Five-year survival following a first admission for heart failure
    • 315-312
    • Stewart S., MacIntyre K., Hole D.J., et al. More "malignant" than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Fail 2001, 3. 315-312.
    • (2001) Eur J Heart Fail , vol.3
    • Stewart, S.1    MacIntyre, K.2    Hole, D.J.3
  • 4
    • 0030972278 scopus 로고    scopus 로고
    • Wasting as independent risk factor for mortality in chronic heart failure
    • Anker S.D., Ponikowski P., Varney S., et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet 1997, 349:1050-1053.
    • (1997) Lancet , vol.349 , pp. 1050-1053
    • Anker, S.D.1    Ponikowski, P.2    Varney, S.3
  • 6
    • 73049177045 scopus 로고
    • Diseases of the heart in the works of Hippokrates
    • Katz A.M., Katz P.B. Diseases of the heart in the works of Hippokrates. Br Heart J 1962, 24:257-264.
    • (1962) Br Heart J , vol.24 , pp. 257-264
    • Katz, A.M.1    Katz, P.B.2
  • 7
    • 0036342402 scopus 로고    scopus 로고
    • Cardiac cachexia in early literature: a review of research prior to Medline
    • Doehner W., Anker S.D. Cardiac cachexia in early literature: a review of research prior to Medline. Int J Cardiol 2002, 85:7-14.
    • (2002) Int J Cardiol , vol.85 , pp. 7-14
    • Doehner, W.1    Anker, S.D.2
  • 8
    • 0036342421 scopus 로고    scopus 로고
    • Epidemiology of weight loss in humans with special reference to wasting in the elderly
    • Wallace J.I., Schwartz R.S. Epidemiology of weight loss in humans with special reference to wasting in the elderly. Int J Cardiol 2002, 85:15-21.
    • (2002) Int J Cardiol , vol.85 , pp. 15-21
    • Wallace, J.I.1    Schwartz, R.S.2
  • 9
    • 34447290920 scopus 로고    scopus 로고
    • Meta-analysis: the effect of dietary counseling for weight loss
    • Dansinger M.L., Tatsioni A., Wong J.B., et al. Meta-analysis: the effect of dietary counseling for weight loss. Ann Intern Med 2007, 147:41-50.
    • (2007) Ann Intern Med , vol.147 , pp. 41-50
    • Dansinger, M.L.1    Tatsioni, A.2    Wong, J.B.3
  • 10
    • 62849107573 scopus 로고    scopus 로고
    • Body-mass index and cause-specific mortality in 900,000 adults: collaborative analyses of 57 prospective studies
    • Prospective Studies Collaboration
    • Whitlock G., Lewington S., et al. Body-mass index and cause-specific mortality in 900,000 adults: collaborative analyses of 57 prospective studies. Lancet 2009, 373(9669):1083-1096. Prospective Studies Collaboration.
    • (2009) Lancet , vol.373 , Issue.9669 , pp. 1083-1096
    • Whitlock, G.1    Lewington, S.2
  • 11
    • 19944427849 scopus 로고    scopus 로고
    • The obesity paradox: body mass index and outcomes in patients with heart failure
    • Curtis J.P., Selter J.G., Wang Y., et al. The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med 2005, 165:55-61.
    • (2005) Arch Intern Med , vol.165 , pp. 55-61
    • Curtis, J.P.1    Selter, J.G.2    Wang, Y.3
  • 12
    • 34548149550 scopus 로고    scopus 로고
    • Body mass index and prognosis in patients with chronic heart failure: insights from the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program
    • Kenchaiah S., Pocock S.J., Wang D., et al. Body mass index and prognosis in patients with chronic heart failure: insights from the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program. Circulation 2007, 116:627-636.
    • (2007) Circulation , vol.116 , pp. 627-636
    • Kenchaiah, S.1    Pocock, S.J.2    Wang, D.3
  • 13
    • 33947356644 scopus 로고    scopus 로고
    • Body mass index, prognosis and mode of death in chronic heart failure: results from the valsartan heart failure trial
    • Cicoira M., Maggioni A.P., Latini R., et al. Body mass index, prognosis and mode of death in chronic heart failure: results from the valsartan heart failure trial. Eur J Heart Fail 2007, 9:397-402.
    • (2007) Eur J Heart Fail , vol.9 , pp. 397-402
    • Cicoira, M.1    Maggioni, A.P.2    Latini, R.3
  • 14
    • 45549097014 scopus 로고    scopus 로고
    • Body mass index and mortality in heart failure: a meta-analysis
    • Oreopoulos A., Padwal R., Kalantar-Zadeh K., et al. Body mass index and mortality in heart failure: a meta-analysis. Am Heart J 2008, 156:13-22.
    • (2008) Am Heart J , vol.156 , pp. 13-22
    • Oreopoulos, A.1    Padwal, R.2    Kalantar-Zadeh, K.3
  • 15
    • 44449112123 scopus 로고    scopus 로고
    • Cachexia: common, deadly, with an urgent need for precise definition and new therapies
    • Lainscak M., Filippatos G., Gheorghiade M., et al. Cachexia: common, deadly, with an urgent need for precise definition and new therapies. Am J Cardiol 2008, 101,8E-10E 2007.
    • (2007) Am J Cardiol 2008, 101,8E-10E
    • Lainscak, M.1    Filippatos, G.2    Gheorghiade, M.3
  • 17
    • 33748167835 scopus 로고    scopus 로고
    • Prognosis and therapy approaches of cardiac cachexia
    • Springer J., Filippatos G., Akashi Y.J., et al. Prognosis and therapy approaches of cardiac cachexia. Curr Opin Cardiol 2006, 21:229-233.
    • (2006) Curr Opin Cardiol , vol.21 , pp. 229-233
    • Springer, J.1    Filippatos, G.2    Akashi, Y.J.3
  • 18
    • 0037471843 scopus 로고    scopus 로고
    • Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study
    • Anker S.D., Negassa A., Coats A.J., et al. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet 2003, 361:1077-1083.
    • (2003) Lancet , vol.361 , pp. 1077-1083
    • Anker, S.D.1    Negassa, A.2    Coats, A.J.3
  • 19
    • 0037300662 scopus 로고    scopus 로고
    • Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity
    • Davos C.H., Doehner W., Rauchhaus M., et al. Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. J Card Fail 2003, 9:29-35.
    • (2003) J Card Fail , vol.9 , pp. 29-35
    • Davos, C.H.1    Doehner, W.2    Rauchhaus, M.3
  • 20
    • 0342460492 scopus 로고    scopus 로고
    • Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia
    • Anker S.D., Chua T.P., Ponikowski P., et al. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 1997, 96:526-534.
    • (1997) Circulation , vol.96 , pp. 526-534
    • Anker, S.D.1    Chua, T.P.2    Ponikowski, P.3
  • 21
    • 0036308682 scopus 로고    scopus 로고
    • The cardiac component of cardiac cachexia
    • Florea V.G., Henein M.Y., Rauchhaus M., et al. The cardiac component of cardiac cachexia. Am Heart J 2002, 144:45-50.
    • (2002) Am Heart J , vol.144 , pp. 45-50
    • Florea, V.G.1    Henein, M.Y.2    Rauchhaus, M.3
  • 22
    • 4444349572 scopus 로고    scopus 로고
    • Wasting of the left ventricle in patients with cardiac cachexia: a cardiovascular magnetic resonance study
    • Florea V.G., Moon J., Pennell D.J., et al. Wasting of the left ventricle in patients with cardiac cachexia: a cardiovascular magnetic resonance study. Int J Cardiol 2004, 97:15-20.
    • (2004) Int J Cardiol , vol.97 , pp. 15-20
    • Florea, V.G.1    Moon, J.2    Pennell, D.J.3
  • 23
    • 33845565186 scopus 로고    scopus 로고
    • Nutrition, metabolism and the complex pathophysiology of cachexia in chronic heart failure
    • von Haehling S., Doehner W., Anker S.D. Nutrition, metabolism and the complex pathophysiology of cachexia in chronic heart failure. Cardiovasc Res 2007, 73:298-309.
    • (2007) Cardiovasc Res , vol.73 , pp. 298-309
    • von Haehling, S.1    Doehner, W.2    Anker, S.D.3
  • 25
    • 33644878162 scopus 로고    scopus 로고
    • Cachexia in chronic heart failure: prognostic implications and novel therapeutic approaches
    • Akashi Y.J., Springer J., Anker S.D. Cachexia in chronic heart failure: prognostic implications and novel therapeutic approaches. Curr Heart Fail Rep 2005, 2:198-203.
    • (2005) Curr Heart Fail Rep , vol.2 , pp. 198-203
    • Akashi, Y.J.1    Springer, J.2    Anker, S.D.3
  • 26
    • 0028363567 scopus 로고
    • Protein-energy malnutrition in patients with ischemic and nonischemic dilated cardiomyopathy and congestive heart failure
    • Schwengel R.H., Gottlieb S.S., Fisher M.L. Protein-energy malnutrition in patients with ischemic and nonischemic dilated cardiomyopathy and congestive heart failure. Am J Cardiol 1994, 73:908-910.
    • (1994) Am J Cardiol , vol.73 , pp. 908-910
    • Schwengel, R.H.1    Gottlieb, S.S.2    Fisher, M.L.3
  • 27
    • 0007096542 scopus 로고    scopus 로고
    • Central regulation of visceral function
    • Appleton & Lange, Stamford, Conn
    • Ganong W.F. Central regulation of visceral function. Review of medical physiology 1999, Appleton & Lange, Stamford, Conn.
    • (1999) Review of medical physiology
    • Ganong, W.F.1
  • 29
    • 0033389977 scopus 로고    scopus 로고
    • Effects of neuropeptide Y on appetite
    • Kokot F., Ficek R. Effects of neuropeptide Y on appetite. Miner Electrolyte Metab 1999, 25:303-305.
    • (1999) Miner Electrolyte Metab , vol.25 , pp. 303-305
    • Kokot, F.1    Ficek, R.2
  • 30
    • 0034073964 scopus 로고    scopus 로고
    • Venous neuropeptide Y receptor responsiveness in patients with chronic heart failure
    • Feng Q., Lambert M.L., Callow I.D., et al. Venous neuropeptide Y receptor responsiveness in patients with chronic heart failure. Clin Pharmacol Ther 2000, 67:292-298.
    • (2000) Clin Pharmacol Ther , vol.67 , pp. 292-298
    • Feng, Q.1    Lambert, M.L.2    Callow, I.D.3
  • 31
    • 0036916019 scopus 로고    scopus 로고
    • Cardiovascular effects and cardiopulmonary plasma gradients following intravenous infusion of neuropeptide Y in humans: negative dromotropic effect on atrioventricular node conduction
    • Ullman B., Pernow J., Lundberg J.M., et al. Cardiovascular effects and cardiopulmonary plasma gradients following intravenous infusion of neuropeptide Y in humans: negative dromotropic effect on atrioventricular node conduction. Clin Sci 2002, 103:535-542.
    • (2002) Clin Sci , vol.103 , pp. 535-542
    • Ullman, B.1    Pernow, J.2    Lundberg, J.M.3
  • 32
    • 0028139089 scopus 로고
    • Positional cloning of the mouse obese gene and its human homologue
    • Zhang Y., Proenca R., Maffei M., et al. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-432.
    • (1994) Nature , vol.372 , pp. 425-432
    • Zhang, Y.1    Proenca, R.2    Maffei, M.3
  • 34
    • 0030936047 scopus 로고    scopus 로고
    • The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure
    • Kennedy A., Gettys T.W., Watson P., et al. The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. J Clin Endocrinol Metab 1997, 82:1293-1300.
    • (1997) J Clin Endocrinol Metab , vol.82 , pp. 1293-1300
    • Kennedy, A.1    Gettys, T.W.2    Watson, P.3
  • 35
    • 2442654859 scopus 로고
    • Identification and expression cloning of a leptin receptor, OB-R
    • Tartaglia L.A., Dembski M., Weng X., et al. Identification and expression cloning of a leptin receptor, OB-R. Cell 1995, 83:1263-1271.
    • (1995) Cell , vol.83 , pp. 1263-1271
    • Tartaglia, L.A.1    Dembski, M.2    Weng, X.3
  • 36
    • 0030039272 scopus 로고    scopus 로고
    • Abnormal splicing of the leptin receptor in diabetic mice
    • Lee G.H., Proenca R., Montez J.M., et al. Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996, 379:632-635.
    • (1996) Nature , vol.379 , pp. 632-635
    • Lee, G.H.1    Proenca, R.2    Montez, J.M.3
  • 37
    • 0030965884 scopus 로고    scopus 로고
    • Expression of the functional leptin receptor mRNA in pancreatic islets and direct inhibitory action of leptin on insulin secretion
    • Emilsson V., Liu Y.L., Cawthorne M.A., et al. Expression of the functional leptin receptor mRNA in pancreatic islets and direct inhibitory action of leptin on insulin secretion. Diabetes 1997, 46:313-316.
    • (1997) Diabetes , vol.46 , pp. 313-316
    • Emilsson, V.1    Liu, Y.L.2    Cawthorne, M.A.3
  • 38
    • 0036230154 scopus 로고    scopus 로고
    • Insulin resistance in moderate chronic heart failure is related to hyperleptinaemia, but not to norepinephrine or TNF-alpha
    • Doehner W., Rauchhaus M., Godsland I.F., et al. Insulin resistance in moderate chronic heart failure is related to hyperleptinaemia, but not to norepinephrine or TNF-alpha. Int J Cardiol 2002, 83:73-81.
    • (2002) Int J Cardiol , vol.83 , pp. 73-81
    • Doehner, W.1    Rauchhaus, M.2    Godsland, I.F.3
  • 39
    • 33644911756 scopus 로고    scopus 로고
    • The endocrine function of adipose tissue: an update
    • Ronti T., Lupattelli G., Mannarino E. The endocrine function of adipose tissue: an update. Clin Endocrinol 2006, 64:355-365.
    • (2006) Clin Endocrinol , vol.64 , pp. 355-365
    • Ronti, T.1    Lupattelli, G.2    Mannarino, E.3
  • 40
    • 13344295079 scopus 로고    scopus 로고
    • Serum immunoreactive-leptin concentrations in normal-weight and obese humans
    • Considine R.V., Sinha M.K., Heiman M.L., et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996, 334:292-295.
    • (1996) N Engl J Med , vol.334 , pp. 292-295
    • Considine, R.V.1    Sinha, M.K.2    Heiman, M.L.3
  • 41
    • 17844391500 scopus 로고    scopus 로고
    • The hardship of obesity: a soft-wired hypothalamus
    • Horvath T.L. The hardship of obesity: a soft-wired hypothalamus. Nat Neurosci 2005, 8:561-565.
    • (2005) Nat Neurosci , vol.8 , pp. 561-565
    • Horvath, T.L.1
  • 42
    • 17844401704 scopus 로고    scopus 로고
    • Anatomy and regulation of the central melanocortin system
    • Cone R.D. Anatomy and regulation of the central melanocortin system. Nat Neurosci 2005, 8:571-578.
    • (2005) Nat Neurosci , vol.8 , pp. 571-578
    • Cone, R.D.1
  • 43
    • 0037043534 scopus 로고    scopus 로고
    • Keeping hunger at bay
    • Schwartz M.W., Morton G.J. Keeping hunger at bay. Nature 2002, 418:595-597.
    • (2002) Nature , vol.418 , pp. 595-597
    • Schwartz, M.W.1    Morton, G.J.2
  • 44
    • 0035942777 scopus 로고    scopus 로고
    • Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus
    • Cowley M.A., Smart J.L., Rubinstein M., et al. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 2001, 411:480-484.
    • (2001) Nature , vol.411 , pp. 480-484
    • Cowley, M.A.1    Smart, J.L.2    Rubinstein, M.3
  • 45
    • 0030899777 scopus 로고    scopus 로고
    • Plasma leptin concentrations and energy expenditure in heart failure patients
    • Toth M.J., Gottlieb S.S., Fisher M.L., et al. Plasma leptin concentrations and energy expenditure in heart failure patients. Metabolism 1997, 46:450-453.
    • (1997) Metabolism , vol.46 , pp. 450-453
    • Toth, M.J.1    Gottlieb, S.S.2    Fisher, M.L.3
  • 46
    • 0035210722 scopus 로고    scopus 로고
    • Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia
    • Doehner W., Pflaum C.D., Rauchhaus M., et al. Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia. Eur J Endocrinol 2001, 145:727-735.
    • (2001) Eur J Endocrinol , vol.145 , pp. 727-735
    • Doehner, W.1    Pflaum, C.D.2    Rauchhaus, M.3
  • 47
    • 0032846516 scopus 로고    scopus 로고
    • Inappropriately low plasma leptin concentration in the cachexia associated with chronic heart failure
    • Murdoch D.R., Rooney E., Dargie H.J., et al. Inappropriately low plasma leptin concentration in the cachexia associated with chronic heart failure. Heart 1999, 82:352-356.
    • (1999) Heart , vol.82 , pp. 352-356
    • Murdoch, D.R.1    Rooney, E.2    Dargie, H.J.3
  • 48
    • 0033677922 scopus 로고    scopus 로고
    • The significance of leptin in humans-do we know it yet?
    • Doehner W., Anker S.D. The significance of leptin in humans-do we know it yet?. Int J Cardiol 2000, 76:122-124.
    • (2000) Int J Cardiol , vol.76 , pp. 122-124
    • Doehner, W.1    Anker, S.D.2
  • 49
    • 0032189670 scopus 로고    scopus 로고
    • Hyperleptinaemia in chronic heart failure. Relationships with insulin
    • Leyva F., Anker S.D., Egerer K., et al. Hyperleptinaemia in chronic heart failure. Relationships with insulin. Eur Heart J 1998, 19:1547-1551.
    • (1998) Eur Heart J , vol.19 , pp. 1547-1551
    • Leyva, F.1    Anker, S.D.2    Egerer, K.3
  • 50
    • 34547791859 scopus 로고    scopus 로고
    • Effects of pro-opiomelanocortin (POMC) on food intake and body weight: mechanisms and therapeutic potential?
    • Coll A.P. Effects of pro-opiomelanocortin (POMC) on food intake and body weight: mechanisms and therapeutic potential?. Clin Sci 2007, 113:171-182.
    • (2007) Clin Sci , vol.113 , pp. 171-182
    • Coll, A.P.1
  • 51
    • 0028134706 scopus 로고
    • Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic circuits in the brain
    • Mountjoy K.G., Mortrud M.T., Low M.J., et al. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic circuits in the brain. Mol Endocrinol 1994, 8:1298-1308.
    • (1994) Mol Endocrinol , vol.8 , pp. 1298-1308
    • Mountjoy, K.G.1    Mortrud, M.T.2    Low, M.J.3
  • 52
    • 0031838353 scopus 로고    scopus 로고
    • Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans
    • Krude H., Biebermann H., Luck W., et al. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 1998, 19:155-157.
    • (1998) Nat Genet , vol.19 , pp. 155-157
    • Krude, H.1    Biebermann, H.2    Luck, W.3
  • 53
    • 0031668219 scopus 로고    scopus 로고
    • A frameshift mutation in MC4R associated with dominantly inherited human obesity
    • Yeo G.S., Farooqi I.S., Aminian S., et al. A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat Genet 1998, 20:111-112.
    • (1998) Nat Genet , vol.20 , pp. 111-112
    • Yeo, G.S.1    Farooqi, I.S.2    Aminian, S.3
  • 54
    • 0031662163 scopus 로고    scopus 로고
    • A frameshift mutation in human MC4R is associated with a dominant form of obesity
    • Vaisse C., Clement K., Guy-Grand B., et al. A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat Genet 1998, 20:113-114.
    • (1998) Nat Genet , vol.20 , pp. 113-114
    • Vaisse, C.1    Clement, K.2    Guy-Grand, B.3
  • 55
    • 34247369437 scopus 로고    scopus 로고
    • The leptin-dependent and -independent melanocortin signaling system: regulation of feeding and energy expenditure
    • Shimizu H., Inoue K., Mori M. The leptin-dependent and -independent melanocortin signaling system: regulation of feeding and energy expenditure. J Endocrinol 2007, 193:1-9.
    • (2007) J Endocrinol , vol.193 , pp. 1-9
    • Shimizu, H.1    Inoue, K.2    Mori, M.3
  • 57
    • 33747054431 scopus 로고    scopus 로고
    • Therapy insight: use of melanocortin antagonists in the treatment of cachexia in chronic disease
    • DeBoer M.D., Marks D.L. Therapy insight: use of melanocortin antagonists in the treatment of cachexia in chronic disease. Nat Clin Pract Endocrinol Metab 2006, 2:459-466.
    • (2006) Nat Clin Pract Endocrinol Metab , vol.2 , pp. 459-466
    • DeBoer, M.D.1    Marks, D.L.2
  • 58
    • 33845373391 scopus 로고    scopus 로고
    • Cachexia in chronic kidney disease: role of inflammation and neuropeptide signaling
    • Mak R.H., Cheung W. Cachexia in chronic kidney disease: role of inflammation and neuropeptide signaling. Curr Opin Nephrol Hypertens 2007, 16:27-31.
    • (2007) Curr Opin Nephrol Hypertens , vol.16 , pp. 27-31
    • Mak, R.H.1    Cheung, W.2
  • 59
    • 34250667431 scopus 로고    scopus 로고
    • Melanocortin interventions in cachexia: how soon from bench to bedside?
    • DeBoer M.D. Melanocortin interventions in cachexia: how soon from bench to bedside?. Curr Opin Clin Nutr Metab Care 2007, 10:457-462.
    • (2007) Curr Opin Clin Nutr Metab Care , vol.10 , pp. 457-462
    • DeBoer, M.D.1
  • 60
    • 0033540056 scopus 로고    scopus 로고
    • Ghrelin is a growth-hormone-releasing acylated peptide from stomach
    • Kojima M., Hosoda H., Date Y., et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999, 402:656-660.
    • (1999) Nature , vol.402 , pp. 656-660
    • Kojima, M.1    Hosoda, H.2    Date, Y.3
  • 61
    • 0033679897 scopus 로고    scopus 로고
    • Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans
    • Date Y., Kojima M., Hosoda H., et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 2000, 141:4255-4261.
    • (2000) Endocrinology , vol.141 , pp. 4255-4261
    • Date, Y.1    Kojima, M.2    Hosoda, H.3
  • 62
    • 0036097362 scopus 로고    scopus 로고
    • Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion
    • Date Y., Nakazato M., Hashiguchi S., et al. Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion. Diabetes 2002, 51:124-129.
    • (2002) Diabetes , vol.51 , pp. 124-129
    • Date, Y.1    Nakazato, M.2    Hashiguchi, S.3
  • 63
    • 0034672457 scopus 로고    scopus 로고
    • Kidney produces a novel acylated peptide, ghrelin
    • Mori K., Yoshimoto A., Takaya K., et al. Kidney produces a novel acylated peptide, ghrelin. FEBS Lett 2000, 486:213-216.
    • (2000) FEBS Lett , vol.486 , pp. 213-216
    • Mori, K.1    Yoshimoto, A.2    Takaya, K.3
  • 64
    • 0035099753 scopus 로고    scopus 로고
    • Ghrelin, a novel placental-derived hormone
    • Gualillo O., Caminos J., Blanco M., et al. Ghrelin, a novel placental-derived hormone. Endocrinology 2001, 142:788-794.
    • (2001) Endocrinology , vol.142 , pp. 788-794
    • Gualillo, O.1    Caminos, J.2    Blanco, M.3
  • 65
    • 9444246501 scopus 로고    scopus 로고
    • A receptor in pituitary and hypothalamus that functions in growth hormone release
    • Howard A.D., Feighner S.D., Cully D.F., et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 1996, 273:974-977.
    • (1996) Science , vol.273 , pp. 974-977
    • Howard, A.D.1    Feighner, S.D.2    Cully, D.F.3
  • 66
    • 0031003664 scopus 로고    scopus 로고
    • Molecular analysis of rat pituitary and hypothalamic growth hormone secretagogue receptors
    • McKee K.K., Palyha O.C., Feighner S.D., et al. Molecular analysis of rat pituitary and hypothalamic growth hormone secretagogue receptors. Mol Endocrinol 1997, 11:415-423.
    • (1997) Mol Endocrinol , vol.11 , pp. 415-423
    • McKee, K.K.1    Palyha, O.C.2    Feighner, S.D.3
  • 67
    • 17744374270 scopus 로고    scopus 로고
    • Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone
    • Arvat E., Maccario M., Di Vito L., et al. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. J Clin Endocrinol Metab 2001, 86:1169-1174.
    • (2001) J Clin Endocrinol Metab , vol.86 , pp. 1169-1174
    • Arvat, E.1    Maccario, M.2    Di Vito, L.3
  • 68
    • 0037456519 scopus 로고    scopus 로고
    • The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis
    • Cowley M.A., Smith R.G., Diano S., et al. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 2003, 37:649-661.
    • (2003) Neuron , vol.37 , pp. 649-661
    • Cowley, M.A.1    Smith, R.G.2    Diano, S.3
  • 69
    • 2542475178 scopus 로고    scopus 로고
    • Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein
    • Chen H.Y., Trumbauer M.E., Chen A.S., et al. Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein. Endocrinology 2004, 145:2607-2612.
    • (2004) Endocrinology , vol.145 , pp. 2607-2612
    • Chen, H.Y.1    Trumbauer, M.E.2    Chen, A.S.3
  • 70
    • 0033784980 scopus 로고    scopus 로고
    • Systemic administration of ghrelin induces Fos and Egr-1 proteins in the hypothalamic arcuate nucleus of fasted and fed rats
    • Hewson A.K., Dickson S.L. Systemic administration of ghrelin induces Fos and Egr-1 proteins in the hypothalamic arcuate nucleus of fasted and fed rats. J Neuroendocrinol 2000, 12:1047-1049.
    • (2000) J Neuroendocrinol , vol.12 , pp. 1047-1049
    • Hewson, A.K.1    Dickson, S.L.2
  • 71
    • 0035514596 scopus 로고    scopus 로고
    • Ghrelin causes hyperphagia and obesity in rats
    • Wren A.M., Small C.J., Abbott C.R., et al. Ghrelin causes hyperphagia and obesity in rats. Diabetes 2001, 50:2540-2547.
    • (2001) Diabetes , vol.50 , pp. 2540-2547
    • Wren, A.M.1    Small, C.J.2    Abbott, C.R.3
  • 72
    • 0038031634 scopus 로고    scopus 로고
    • Growth hormone secretagogue receptor expression in the cells of the stomach-projected afferent nerve in the rat nodose ganglion
    • Sakata I., Yamazaki M., Inoue K., et al. Growth hormone secretagogue receptor expression in the cells of the stomach-projected afferent nerve in the rat nodose ganglion. Neurosci Lett 2003, 342:183-186.
    • (2003) Neurosci Lett , vol.342 , pp. 183-186
    • Sakata, I.1    Yamazaki, M.2    Inoue, K.3
  • 73
    • 3042735648 scopus 로고    scopus 로고
    • The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans
    • Gnanapavan S., Kola B., Bustin S.A., et al. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 2002, 87:2988.
    • (2002) J Clin Endocrinol Metab , vol.87 , pp. 2988
    • Gnanapavan, S.1    Kola, B.2    Bustin, S.A.3
  • 74
    • 5644271873 scopus 로고    scopus 로고
    • Effects of ghrelin on the proliferation and secretion of splenic T lymphocytes in mice
    • Xia Q., Pang W., Pan H., et al. Effects of ghrelin on the proliferation and secretion of splenic T lymphocytes in mice. Regul Pept 2004, 122:173-178.
    • (2004) Regul Pept , vol.122 , pp. 173-178
    • Xia, Q.1    Pang, W.2    Pan, H.3
  • 75
    • 0041706227 scopus 로고    scopus 로고
    • Therapeutic effects of ghrelin on endotoxic shock in rats
    • Chang L., Zhao J., Yang J., et al. Therapeutic effects of ghrelin on endotoxic shock in rats. Eur J Pharmacol 2003, 473:171-176.
    • (2003) Eur J Pharmacol , vol.473 , pp. 171-176
    • Chang, L.1    Zhao, J.2    Yang, J.3
  • 76
    • 2442419837 scopus 로고    scopus 로고
    • Ghrelin inhibits proinflammatory responses and nuclear factor-kappaB activation in human endothelial cells
    • Li W.G., Gavrila D., Liu X., et al. Ghrelin inhibits proinflammatory responses and nuclear factor-kappaB activation in human endothelial cells. Circulation 2004, 109:2221-2226.
    • (2004) Circulation , vol.109 , pp. 2221-2226
    • Li, W.G.1    Gavrila, D.2    Liu, X.3
  • 77
    • 0035940390 scopus 로고    scopus 로고
    • Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors
    • Nagaya N., Uematsu M., Kojima M., et al. Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors. Circulation 2001, 104:2034-2038.
    • (2001) Circulation , vol.104 , pp. 2034-2038
    • Nagaya, N.1    Uematsu, M.2    Kojima, M.3
  • 78
    • 20844460120 scopus 로고    scopus 로고
    • Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure
    • Nagaya N., Moriya J., Yasumura Y., et al. Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation 2004, 110:3674-3679.
    • (2004) Circulation , vol.110 , pp. 3674-3679
    • Nagaya, N.1    Moriya, J.2    Yasumura, Y.3
  • 79
    • 0035908954 scopus 로고    scopus 로고
    • Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure
    • Nagaya N., Uematsu M., Kojima M., et al. Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation 2001, 104:1430-1435.
    • (2001) Circulation , vol.104 , pp. 1430-1435
    • Nagaya, N.1    Uematsu, M.2    Kojima, M.3
  • 80
    • 70749095878 scopus 로고    scopus 로고
    • No effects of human ghrelin on cardiac function despite profound effects on body composition in a rat model of heart failure
    • (Pubmed ahead of print
    • Akashi Y.J., Palus S., Datta R., et al. No effects of human ghrelin on cardiac function despite profound effects on body composition in a rat model of heart failure. Int J Cardiol 2008, (Pubmed ahead of print.
    • (2008) Int J Cardiol
    • Akashi, Y.J.1    Palus, S.2    Datta, R.3
  • 81
    • 57149137502 scopus 로고    scopus 로고
    • Effects of ghrelin treatment on patients undergoing total hip replacement for osteoarthritis: different outcomes from studies in patients with cardiac and pulmonary cachexia
    • Akamizu T., Iwakura H., Ariyasu H., et al. Effects of ghrelin treatment on patients undergoing total hip replacement for osteoarthritis: different outcomes from studies in patients with cardiac and pulmonary cachexia. J Am Geriatr Soc 2008, 56:2363-2365.
    • (2008) J Am Geriatr Soc , vol.56 , pp. 2363-2365
    • Akamizu, T.1    Iwakura, H.2    Ariyasu, H.3
  • 82
    • 0036432925 scopus 로고    scopus 로고
    • Adiponectin: a link between excess adiposity and associated comorbidities?
    • Ukkola O., Santaniemi M. Adiponectin: a link between excess adiposity and associated comorbidities?. J Mol Med 2002, 80:696-702.
    • (2002) J Mol Med , vol.80 , pp. 696-702
    • Ukkola, O.1    Santaniemi, M.2
  • 83
    • 33845238731 scopus 로고    scopus 로고
    • Low plasma adiponectin concentration is an indicator of the metabolic syndrome
    • Santaniemi M., Kesäniemi Y.A., Ukkola O. Low plasma adiponectin concentration is an indicator of the metabolic syndrome. Eur J Endocrinol 2006, 155:745-750.
    • (2006) Eur J Endocrinol , vol.155 , pp. 745-750
    • Santaniemi, M.1    Kesäniemi, Y.A.2    Ukkola, O.3
  • 84
    • 0037356826 scopus 로고    scopus 로고
    • The role of the novel adipocyte-derived hormone adiponectin in human disease
    • Díez J.J., Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 2003, 148:293-300.
    • (2003) Eur J Endocrinol , vol.148 , pp. 293-300
    • Díez, J.J.1    Iglesias, P.2
  • 85
    • 33745174474 scopus 로고    scopus 로고
    • Abnormalities of whole body protein turnover, muscle metabolism and levels of metabolic hormones in patients with chronic heart failure
    • Nørrelund H., Wiggers H., Halbirk M., et al. Abnormalities of whole body protein turnover, muscle metabolism and levels of metabolic hormones in patients with chronic heart failure. J Intern Med 2006, 26:11-21.
    • (2006) J Intern Med , vol.26 , pp. 11-21
    • Nørrelund, H.1    Wiggers, H.2    Halbirk, M.3
  • 86
    • 34548355070 scopus 로고    scopus 로고
    • Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide
    • McEntegart M.B., Awede B., Petrie M.C., et al. Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide. Eur Heart J 2007, 28:829-835.
    • (2007) Eur Heart J , vol.28 , pp. 829-835
    • McEntegart, M.B.1    Awede, B.2    Petrie, M.C.3
  • 87
    • 33750080744 scopus 로고    scopus 로고
    • Circulating adiponectin concentrations in patients with congestive heart failure
    • George J., Patal S., Wexler D., et al. Circulating adiponectin concentrations in patients with congestive heart failure. Heart 2006, 92:1420-1424.
    • (2006) Heart , vol.92 , pp. 1420-1424
    • George, J.1    Patal, S.2    Wexler, D.3
  • 88
    • 33751423824 scopus 로고    scopus 로고
    • Association of hyperadiponectinemia with severity of ventricular dysfunction in congestive heart failure
    • Nakamura T., Funayama H., Kubo N., et al. Association of hyperadiponectinemia with severity of ventricular dysfunction in congestive heart failure. Circ J 2006, 70:1557-1562.
    • (2006) Circ J , vol.70 , pp. 1557-1562
    • Nakamura, T.1    Funayama, H.2    Kubo, N.3
  • 89
    • 25444506344 scopus 로고    scopus 로고
    • Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure
    • Kistorp C., Faber J., Galatius S., et al. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 2005, 112:1756-1762.
    • (2005) Circulation , vol.112 , pp. 1756-1762
    • Kistorp, C.1    Faber, J.2    Galatius, S.3
  • 90
    • 0025286817 scopus 로고
    • Elevated circulating levels of tumor necrosis factor in severe chronic heart failure
    • Levine B., Kalman J., Mayer L., et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990, 323:236-241.
    • (1990) N Engl J Med , vol.323 , pp. 236-241
    • Levine, B.1    Kalman, J.2    Mayer, L.3
  • 91
    • 0035064105 scopus 로고    scopus 로고
    • Recent insights into the role of tumor necrosis factor in the failing heart
    • Mann D.L. Recent insights into the role of tumor necrosis factor in the failing heart. Heart Fail Rev 2001, 6:71-80.
    • (2001) Heart Fail Rev , vol.6 , pp. 71-80
    • Mann, D.L.1
  • 92
    • 0028171632 scopus 로고
    • Increased circulating cytokines in patients with myocarditis and cardiomyopathy
    • Matsumori A., Yamada T., Suzuki H., et al. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J 1994, 72:561-566.
    • (1994) Br Heart J , vol.72 , pp. 561-566
    • Matsumori, A.1    Yamada, T.2    Suzuki, H.3
  • 93
    • 0031977811 scopus 로고    scopus 로고
    • Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure
    • Tsutamoto T., Hisanaga T., Wada A., et al. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J Am Coll Cardiol 1998, 31:391-398.
    • (1998) J Am Coll Cardiol , vol.31 , pp. 391-398
    • Tsutamoto, T.1    Hisanaga, T.2    Wada, A.3
  • 94
    • 0030977889 scopus 로고    scopus 로고
    • Elevated soluble CD14 receptors and altered cytokines in chronic heart failure
    • Anker S.D., Egerer K.R., Volk H.D., et al. Elevated soluble CD14 receptors and altered cytokines in chronic heart failure. Am J Cardiol 1997, 79:1426-1430.
    • (1997) Am J Cardiol , vol.79 , pp. 1426-1430
    • Anker, S.D.1    Egerer, K.R.2    Volk, H.D.3
  • 95
    • 0036890211 scopus 로고    scopus 로고
    • Pathophysiologic quantities of endotoxin-induced tumor necrosis factor-alpha release in whole blood from patients with chronic heart failure
    • Genth-Zotz S., von Haehling S., Bolger A.P., et al. Pathophysiologic quantities of endotoxin-induced tumor necrosis factor-alpha release in whole blood from patients with chronic heart failure. Am J Cardiol 2002, 90:1226-1230.
    • (2002) Am J Cardiol , vol.90 , pp. 1226-1230
    • Genth-Zotz, S.1    von Haehling, S.2    Bolger, A.P.3
  • 96
    • 0033614672 scopus 로고    scopus 로고
    • Endotoxin and immune activation in chronic heart failure: a prospective cohort study
    • Niebauer J., Volk H.D., Kemp M., et al. Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet 1999, 353:1838-1842.
    • (1999) Lancet , vol.353 , pp. 1838-1842
    • Niebauer, J.1    Volk, H.D.2    Kemp, M.3
  • 97
    • 0030457101 scopus 로고    scopus 로고
    • Metabolic actions of growth hormone in man
    • Ho K.K., O'Sullivan A.J., Hoffman D.M. Metabolic actions of growth hormone in man. Endocr J 1996, 43(suppl):S57-S63.
    • (1996) Endocr J , vol.43 , Issue.SUPPL.
    • Ho, K.K.1    O'Sullivan, A.J.2    Hoffman, D.M.3
  • 98
    • 0002969156 scopus 로고
    • Normal and aberrant growth
    • WB Saunders, Philadelphia, J.D. Wilson, D.D. Foster (Eds.)
    • Underwood L.E., Van Wyk J.J. Normal and aberrant growth. Williams textbook of endocrinology 1992, WB Saunders, Philadelphia. J.D. Wilson, D.D. Foster (Eds.).
    • (1992) Williams textbook of endocrinology
    • Underwood, L.E.1    Van Wyk, J.J.2
  • 99
    • 0032775336 scopus 로고    scopus 로고
    • Effect of insulin-like growth factor-1 (IGF-1) on muscle and bone growth in experimental models
    • Tirapegui J. Effect of insulin-like growth factor-1 (IGF-1) on muscle and bone growth in experimental models. Int J Food Sci Nutr 1999, 50:231-236.
    • (1999) Int J Food Sci Nutr , vol.50 , pp. 231-236
    • Tirapegui, J.1
  • 100
    • 0032565361 scopus 로고    scopus 로고
    • Randomised, double blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy
    • Osterziel K.J., Strohm O., Schuler J., et al. Randomised, double blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy. Lancet 1998, 351:1233-1237.
    • (1998) Lancet , vol.351 , pp. 1233-1237
    • Osterziel, K.J.1    Strohm, O.2    Schuler, J.3
  • 101
    • 0029799510 scopus 로고    scopus 로고
    • Growth hormone in the treatment of dilated cardiomyopathy
    • Frustaci A., Gentiloni N., Russo M.A. Growth hormone in the treatment of dilated cardiomyopathy. N Engl J Med 1996, 335:672-673.
    • (1996) N Engl J Med , vol.335 , pp. 672-673
    • Frustaci, A.1    Gentiloni, N.2    Russo, M.A.3
  • 102
    • 0032213494 scopus 로고    scopus 로고
    • A placebo-controlled study of growth hormone in patients with congestive heart failure
    • Isgaard J., Bergh C.H., Caidahl K., et al. A placebo-controlled study of growth hormone in patients with congestive heart failure. Eur Heart J 1998, 19:1704-1711.
    • (1998) Eur Heart J , vol.19 , pp. 1704-1711
    • Isgaard, J.1    Bergh, C.H.2    Caidahl, K.3
  • 103
    • 0034897735 scopus 로고    scopus 로고
    • Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone
    • Anker S.D., Volterrani M., Pflaum C.D., et al. Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone. J Am Coll Cardiol 2001, 38:443-452.
    • (2001) J Am Coll Cardiol , vol.38 , pp. 443-452
    • Anker, S.D.1    Volterrani, M.2    Pflaum, C.D.3
  • 104
    • 0028080510 scopus 로고
    • Insulin resistance in chronic heart failure
    • Swan J.W., Walton C., Godsland I.F., et al. Insulin resistance in chronic heart failure. Eur Heart J 1994, 15:1528-1532.
    • (1994) Eur Heart J , vol.15 , pp. 1528-1532
    • Swan, J.W.1    Walton, C.2    Godsland, I.F.3
  • 105
    • 0037336371 scopus 로고    scopus 로고
    • The Euroheart failure survey programme-a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis
    • Cleland J.G., Swedberg K., Follath F., et al. The Euroheart failure survey programme-a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 2003, 24:442-463.
    • (2003) Eur Heart J , vol.24 , pp. 442-463
    • Cleland, J.G.1    Swedberg, K.2    Follath, F.3
  • 106
    • 0033886497 scopus 로고    scopus 로고
    • Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure
    • Suskin N., McKelvie R.S., Burns R.J., et al. Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure. Eur Heart J 2000, 21:1368-1375.
    • (2000) Eur Heart J , vol.21 , pp. 1368-1375
    • Suskin, N.1    McKelvie, R.S.2    Burns, R.J.3
  • 107
    • 0035810983 scopus 로고    scopus 로고
    • Glycemic control and heart failure among adult patients with diabetes
    • Iribarren C., Karter A.J., Go A.S., et al. Glycemic control and heart failure among adult patients with diabetes. Circulation 2001, 103:2668-2673.
    • (2001) Circulation , vol.103 , pp. 2668-2673
    • Iribarren, C.1    Karter, A.J.2    Go, A.S.3
  • 108
    • 0030751957 scopus 로고    scopus 로고
    • Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure
    • Swan J.W., Anker S.D., Walton C., et al. Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. J Am Coll Cardiol 1997, 30:527-532.
    • (1997) J Am Coll Cardiol , vol.30 , pp. 527-532
    • Swan, J.W.1    Anker, S.D.2    Walton, C.3
  • 109
    • 24944519346 scopus 로고    scopus 로고
    • Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure
    • Doehner W., Rauchhaus M., Ponikowski P., et al. Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure. J Am Coll Cardiol 2005, 46:1019-1026.
    • (2005) J Am Coll Cardiol , vol.46 , pp. 1019-1026
    • Doehner, W.1    Rauchhaus, M.2    Ponikowski, P.3
  • 110
    • 70749131551 scopus 로고    scopus 로고
    • Reduced glucose transporter GLUT4 in skeletal muscle predicts insulin resistance in non-diabetic chronic heart failure patients independently of body composition
    • Doehner W., Gathercole D., Cicoira M., et al. Reduced glucose transporter GLUT4 in skeletal muscle predicts insulin resistance in non-diabetic chronic heart failure patients independently of body composition. Int J Cardiol 2010.
    • (2010) Int J Cardiol
    • Doehner, W.1    Gathercole, D.2    Cicoira, M.3
  • 111
    • 38149052593 scopus 로고    scopus 로고
    • Xanthine oxidase inhibitors and insulin sensitizers
    • CRC Press, Boca Raton, Fla, K.G. Hofbauer, S.D. Anker, A. Inui (Eds.)
    • Doehner W. Xanthine oxidase inhibitors and insulin sensitizers. Pharmacotherapy of cachexia 2006, CRC Press, Boca Raton, Fla. K.G. Hofbauer, S.D. Anker, A. Inui (Eds.).
    • (2006) Pharmacotherapy of cachexia
    • Doehner, W.1
  • 112
    • 37149034178 scopus 로고    scopus 로고
    • Thiazolidinediones and cardiovascular outcomes in older patients with diabetes
    • Lipscombe L.L., Gomes T., Lévesque L.E., et al. Thiazolidinediones and cardiovascular outcomes in older patients with diabetes. JAMA 2007, 298(22):2634-2643.
    • (2007) JAMA , vol.298 , Issue.22 , pp. 2634-2643
    • Lipscombe, L.L.1    Gomes, T.2    Lévesque, L.E.3
  • 113
    • 47849123996 scopus 로고    scopus 로고
    • Pioglitazone and heart failure: results from a controlled study in patients with type 2 diabetes mellitus and systolic dysfunction
    • Giles T.D., Miller A.B., Elkayam U., et al. Pioglitazone and heart failure: results from a controlled study in patients with type 2 diabetes mellitus and systolic dysfunction. J Card Fail 2008, 14(6):445-452.
    • (2008) J Card Fail , vol.14 , Issue.6 , pp. 445-452
    • Giles, T.D.1    Miller, A.B.2    Elkayam, U.3
  • 114
    • 13444272949 scopus 로고    scopus 로고
    • Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study
    • Masoudi F.A., Inzucchi S.E., Wang Y., et al. Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study. Circulation 2005, 111:583-590.
    • (2005) Circulation , vol.111 , pp. 583-590
    • Masoudi, F.A.1    Inzucchi, S.E.2    Wang, Y.3
  • 115
    • 9644302851 scopus 로고    scopus 로고
    • Association between congestive heart failure and hospitalization in patients with type 2 diabetes mellitus receiving treatment with insulin or pioglitazone: a retrospective data analysis
    • Rajagopalan R., Rosenson R.S., Fernandes A.W., et al. Association between congestive heart failure and hospitalization in patients with type 2 diabetes mellitus receiving treatment with insulin or pioglitazone: a retrospective data analysis. Clin Ther 2004, 26:1400-1410.
    • (2004) Clin Ther , vol.26 , pp. 1400-1410
    • Rajagopalan, R.1    Rosenson, R.S.2    Fernandes, A.W.3
  • 116
    • 34247153877 scopus 로고    scopus 로고
    • A randomized, placebo-controlled trial assessing the effects of rosiglitazone on echocardiographic function and cardiac status in type 2 diabetic patients with New York Heart Association Functional Class I or II heart failure
    • Dargie H.J., Hildebrandt P.R., Riegger G.A., et al. A randomized, placebo-controlled trial assessing the effects of rosiglitazone on echocardiographic function and cardiac status in type 2 diabetic patients with New York Heart Association Functional Class I or II heart failure. J Am Coll Cardiol 2007, 49:1696-1704.
    • (2007) J Am Coll Cardiol , vol.49 , pp. 1696-1704
    • Dargie, H.J.1    Hildebrandt, P.R.2    Riegger, G.A.3
  • 117
    • 34250212715 scopus 로고    scopus 로고
    • Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes
    • Nissen S.E., Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 2007, 356:2457-2471.
    • (2007) N Engl J Med , vol.356 , pp. 2457-2471
    • Nissen, S.E.1    Wolski, K.2
  • 118
    • 0026554586 scopus 로고
    • Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure
    • Mancini D.M., Walter G., Reichek N., et al. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation 1992, 85:1364-1373.
    • (1992) Circulation , vol.85 , pp. 1364-1373
    • Mancini, D.M.1    Walter, G.2    Reichek, N.3
  • 119
    • 0032961878 scopus 로고    scopus 로고
    • Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure
    • Anker S.D., Ponikowski P.P., Clark A.L., et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure. Eur Heart J 1999, 20:683-693.
    • (1999) Eur Heart J , vol.20 , pp. 683-693
    • Anker, S.D.1    Ponikowski, P.P.2    Clark, A.L.3
  • 120
    • 11144356337 scopus 로고    scopus 로고
    • Foxo transcription factors induce the atrophy related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy
    • Sandri M., Sandri C., Gilbert A., et al. Foxo transcription factors induce the atrophy related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 2004, 117(3):399-412.
    • (2004) Cell , vol.117 , Issue.3 , pp. 399-412
    • Sandri, M.1    Sandri, C.2    Gilbert, A.3
  • 121
    • 0036051296 scopus 로고    scopus 로고
    • Origin of symptoms in patients with cachexia with special reference to weakness and shortness of breath
    • Coats A.J. Origin of symptoms in patients with cachexia with special reference to weakness and shortness of breath. Int J Cardiol 2002, 85(1):133-139.
    • (2002) Int J Cardiol , vol.85 , Issue.1 , pp. 133-139
    • Coats, A.J.1
  • 122
    • 0031025867 scopus 로고    scopus 로고
    • The influence of muscle mass, strength, fatigability and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failure
    • Anker S.D., Swan J.W., Volterrani M., et al. The influence of muscle mass, strength, fatigability and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failure. Eur Heart J 1997, 18(2):259-269.
    • (1997) Eur Heart J , vol.18 , Issue.2 , pp. 259-269
    • Anker, S.D.1    Swan, J.W.2    Volterrani, M.3
  • 123
    • 0019378153 scopus 로고
    • Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure
    • Franciosa J.A., Park M., Levine T.B. Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure. Am J Cardiol 1981, 47:33-39.
    • (1981) Am J Cardiol , vol.47 , pp. 33-39
    • Franciosa, J.A.1    Park, M.2    Levine, T.B.3
  • 124
    • 0031539407 scopus 로고    scopus 로고
    • Skeletal muscle function and its relation to exercise tolerance in chronic heart failure
    • Harrington D., Anker S.D., Chua T.P., et al. Skeletal muscle function and its relation to exercise tolerance in chronic heart failure. J Am Coll Cardiol 1997, 30:1758-1764.
    • (1997) J Am Coll Cardiol , vol.30 , pp. 1758-1764
    • Harrington, D.1    Anker, S.D.2    Chua, T.P.3
  • 125
    • 0028124661 scopus 로고
    • Symptoms and quality of life in heart failure: the muscle hypothesis
    • Coats A.J., Clark A.L., Piepoli M., et al. Symptoms and quality of life in heart failure: the muscle hypothesis. Br Heart J 1994, 72(suppl 2):S36-S39.
    • (1994) Br Heart J , vol.72 , Issue.SUPPL. 2
    • Coats, A.J.1    Clark, A.L.2    Piepoli, M.3
  • 126
    • 0021206426 scopus 로고
    • Exercise intolerance in patients with chronic heart failure: role of impaired nutritive flow to skeletal muscle
    • Wilson J.R., Martin J.L., Schwartz D., et al. Exercise intolerance in patients with chronic heart failure: role of impaired nutritive flow to skeletal muscle. Circulation 1984, 69(6):1079-1087.
    • (1984) Circulation , vol.69 , Issue.6 , pp. 1079-1087
    • Wilson, J.R.1    Martin, J.L.2    Schwartz, D.3
  • 127
    • 3042706719 scopus 로고    scopus 로고
    • Comparisons of the skeletal muscle metabolic abnormalities in the arm and leg muscles of patients with chronic heart failure
    • Nagai T., Okita K., Yonezawa K., Yamada Y., et al. Comparisons of the skeletal muscle metabolic abnormalities in the arm and leg muscles of patients with chronic heart failure. Circ J 2004, 68(6):573-579.
    • (2004) Circ J , vol.68 , Issue.6 , pp. 573-579
    • Nagai, T.1    Okita, K.2    Yonezawa, K.3    Yamada, Y.4
  • 128
    • 21244431648 scopus 로고    scopus 로고
    • Lipid mobilization with physiological atrial natriuretic peptide concentrations in humans
    • Birkenfeld A.L., Boschmann M., Moro C., et al. Lipid mobilization with physiological atrial natriuretic peptide concentrations in humans. J Clin Endocrinol Metab 2005, 90:3622-3628.
    • (2005) J Clin Endocrinol Metab , vol.90 , pp. 3622-3628
    • Birkenfeld, A.L.1    Boschmann, M.2    Moro, C.3
  • 129
    • 42949109612 scopus 로고    scopus 로고
    • Control of lipolysis by natriuretic peptides and cyclic GMP
    • Lafontan M., Moro C., Berlan M., et al. Control of lipolysis by natriuretic peptides and cyclic GMP. Trends Endocrinol Metab 2008, 19:130-137.
    • (2008) Trends Endocrinol Metab , vol.19 , pp. 130-137
    • Lafontan, M.1    Moro, C.2    Berlan, M.3
  • 130
    • 34147154839 scopus 로고    scopus 로고
    • Atrial natriuretic peptide inhibits the production of adipokines and cytokines linked to inflammation and insulin resistance in human subcutaneous adipose tissue
    • Moro C., Klimcakova E., Lolmède K., et al. Atrial natriuretic peptide inhibits the production of adipokines and cytokines linked to inflammation and insulin resistance in human subcutaneous adipose tissue. Diabetologia 2007, 50:1038-1047.
    • (2007) Diabetologia , vol.50 , pp. 1038-1047
    • Moro, C.1    Klimcakova, E.2    Lolmède, K.3
  • 131
    • 33846621473 scopus 로고    scopus 로고
    • Fat loss in cachexia-is there a role for adipocyte lipolysis?
    • Ryden M., Arner P. Fat loss in cachexia-is there a role for adipocyte lipolysis?. Clin Nutr 2007, 26:1-6.
    • (2007) Clin Nutr , vol.26 , pp. 1-6
    • Ryden, M.1    Arner, P.2
  • 132
    • 0024424410 scopus 로고
    • Cardiovascular and metabolic response to adrenaline infusion in weight-losing patients with and without cancer
    • Drott C., Persson H., Lundholm K. Cardiovascular and metabolic response to adrenaline infusion in weight-losing patients with and without cancer. Clin Physiol 1989, 9:427-439.
    • (1989) Clin Physiol , vol.9 , pp. 427-439
    • Drott, C.1    Persson, H.2    Lundholm, K.3
  • 133
    • 0034235124 scopus 로고    scopus 로고
    • Lipolysis and lipid oxidation in weight-losing cancer patients and healthy subjects
    • Zuijdgeest-van Leeuwen S.D., van den Berg J.W., Wattimena J.L., et al. Lipolysis and lipid oxidation in weight-losing cancer patients and healthy subjects. Metabolism 2000, 49:931-936.
    • (2000) Metabolism , vol.49 , pp. 931-936
    • Zuijdgeest-van Leeuwen, S.D.1    van den Berg, J.W.2    Wattimena, J.L.3
  • 134
    • 0345737279 scopus 로고    scopus 로고
    • Tumour necrosis factor-alpha and the failing heart-pathophysiology and therapeutic implications
    • von Haehling S., Jankowska E.A., Anker S.D. Tumour necrosis factor-alpha and the failing heart-pathophysiology and therapeutic implications. Basic Res Cardiol 2004, 99:18-28.
    • (2004) Basic Res Cardiol , vol.99 , pp. 18-28
    • von Haehling, S.1    Jankowska, E.A.2    Anker, S.D.3
  • 135
    • 0028047485 scopus 로고
    • Osteoporosis and bone morbidity in cardiac transplant recipients
    • Lee A.H., Mull R.L., Keenan G.F., et al. Osteoporosis and bone morbidity in cardiac transplant recipients. Am J Med 1994, 96:35-41.
    • (1994) Am J Med , vol.96 , pp. 35-41
    • Lee, A.H.1    Mull, R.L.2    Keenan, G.F.3
  • 136
    • 67649794856 scopus 로고    scopus 로고
    • Osteoporosis and congestive heart failure (CHF) in the elderly patient: double disease burden
    • Abou-Raya S., Abou-Raya A. Osteoporosis and congestive heart failure (CHF) in the elderly patient: double disease burden. Arch Gerontol Geriatr 2008, 49:250-254.
    • (2008) Arch Gerontol Geriatr , vol.49 , pp. 250-254
    • Abou-Raya, S.1    Abou-Raya, A.2
  • 137
    • 0033557630 scopus 로고    scopus 로고
    • Loss of bone mineral in patients with cachexia due to chronic heart failure
    • Anker S.D., Clark A.L., Teixeira M.M., et al. Loss of bone mineral in patients with cachexia due to chronic heart failure. Am J Cardiol 1999, 83:612-615.
    • (1999) Am J Cardiol , vol.83 , pp. 612-615
    • Anker, S.D.1    Clark, A.L.2    Teixeira, M.M.3
  • 138
    • 0030852304 scopus 로고    scopus 로고
    • Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure
    • Shane E., Mancini D., Aaronson K., et al. Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. Am J Med 1997, 103:197-207.
    • (1997) Am J Med , vol.103 , pp. 197-207
    • Shane, E.1    Mancini, D.2    Aaronson, K.3
  • 139
    • 29244445119 scopus 로고    scopus 로고
    • Weight loss, muscle strength, and angiotensin-converting enzyme inhibitors in older adults with congestive heart failure or hypertension
    • Schellenbaum G.D., Smith N.L., Heckbert S.R., et al. Weight loss, muscle strength, and angiotensin-converting enzyme inhibitors in older adults with congestive heart failure or hypertension. J Am Geriatr Soc 2005, 53:2030-2031.
    • (2005) J Am Geriatr Soc , vol.53 , pp. 2030-2031
    • Schellenbaum, G.D.1    Smith, N.L.2    Heckbert, S.R.3
  • 140
    • 0029146638 scopus 로고
    • Lisinopril administration improves insulin action in aged patients with hypertension
    • Paolisso G., Balbi V., Gambardella A., et al. Lisinopril administration improves insulin action in aged patients with hypertension. J Hum Hypertens 1995, 9:541-546.
    • (1995) J Hum Hypertens , vol.9 , pp. 541-546
    • Paolisso, G.1    Balbi, V.2    Gambardella, A.3
  • 141
    • 0035904369 scopus 로고    scopus 로고
    • Ramipril and the development of diabetes
    • Yusuf S., Gerstein H., Hoogwerf B., et al. Ramipril and the development of diabetes. JAMA 2001, 286:1882-1885.
    • (2001) JAMA , vol.286 , pp. 1882-1885
    • Yusuf, S.1    Gerstein, H.2    Hoogwerf, B.3
  • 142
    • 33846294746 scopus 로고    scopus 로고
    • Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis
    • Elliott W.J., Meyer P.M. Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet 2007, 369:201-207.
    • (2007) Lancet , vol.369 , pp. 201-207
    • Elliott, W.J.1    Meyer, P.M.2
  • 143
    • 33646778517 scopus 로고    scopus 로고
    • Adipose tissue lipolysis as a metabolic pathway to define pharmacological strategies against obesity and the metabolic syndrome
    • Langin D. Adipose tissue lipolysis as a metabolic pathway to define pharmacological strategies against obesity and the metabolic syndrome. Pharmacol Res 2006, 53:482-491.
    • (2006) Pharmacol Res , vol.53 , pp. 482-491
    • Langin, D.1
  • 144
    • 0033866542 scopus 로고    scopus 로고
    • The major components of human energy balance during chronic beta-adrenergic blockade
    • Lamont L.S., Brown T., Riebe D., et al. The major components of human energy balance during chronic beta-adrenergic blockade. J Cardiopulm Rehabil 2000, 20:247-250.
    • (2000) J Cardiopulm Rehabil , vol.20 , pp. 247-250
    • Lamont, L.S.1    Brown, T.2    Riebe, D.3
  • 145
    • 0041442580 scopus 로고    scopus 로고
    • Does carvedilol prevent and reverse cardiac cachexia in patients with severe heart failure? Results of the COPERNICUS study
    • (abstract)
    • Anker S.D., Coats A.J., Roecker E.B., et al. Does carvedilol prevent and reverse cardiac cachexia in patients with severe heart failure? Results of the COPERNICUS study. Eur Heart J 2002, 23:394. (abstract).
    • (2002) Eur Heart J , vol.23 , pp. 394
    • Anker, S.D.1    Coats, A.J.2    Roecker, E.B.3
  • 146
    • 18844443240 scopus 로고    scopus 로고
    • Prevention and reversal of cachexia in patients with chronic heart failure by bisoprolol: results from the CIBIS II-study
    • (abstract)
    • Anker S.D., Lechat P., Dargie H.J. Prevention and reversal of cachexia in patients with chronic heart failure by bisoprolol: results from the CIBIS II-study. J Am Coll Cardiol 2003, 41:156A-157A. (abstract).
    • (2003) J Am Coll Cardiol , vol.41
    • Anker, S.D.1    Lechat, P.2    Dargie, H.J.3
  • 147
    • 28844438290 scopus 로고    scopus 로고
    • Body composition changes in patients with systolic heart failure treated with beta blockers: a pilot study
    • Lainscak M., Keber I., Anker S.D. Body composition changes in patients with systolic heart failure treated with beta blockers: a pilot study. Int J Cardiol 2006, 106:319-322.
    • (2006) Int J Cardiol , vol.106 , pp. 319-322
    • Lainscak, M.1    Keber, I.2    Anker, S.D.3
  • 148
    • 0347595456 scopus 로고    scopus 로고
    • Partial reversal of cachexia by beta-adrenergic receptor blocker therapy in patients with chronic heart failure
    • Hryniewicz K., Androne A.S., Hudaihed A., et al. Partial reversal of cachexia by beta-adrenergic receptor blocker therapy in patients with chronic heart failure. J Card Fail 2003, 9:464-468.
    • (2003) J Card Fail , vol.9 , pp. 464-468
    • Hryniewicz, K.1    Androne, A.S.2    Hudaihed, A.3
  • 149
    • 0035950685 scopus 로고    scopus 로고
    • Reversal of catabolism by beta-blockade after severe burns
    • Herndon D.N., Hart D.W., Wolf S.E., et al. Reversal of catabolism by beta-blockade after severe burns. N Engl J Med 2001, 345:1223-1229.
    • (2001) N Engl J Med , vol.345 , pp. 1223-1229
    • Herndon, D.N.1    Hart, D.W.2    Wolf, S.E.3
  • 150
    • 0028700548 scopus 로고
    • The effect of the beta-adrenergic agonist clenbuterol on the growth of skeletal muscles of rats
    • Rehfeldt C., Weikard R., Reichel K. The effect of the beta-adrenergic agonist clenbuterol on the growth of skeletal muscles of rats. Arch Tierernahr 1994, 45:333-344.
    • (1994) Arch Tierernahr , vol.45 , pp. 333-344
    • Rehfeldt, C.1    Weikard, R.2    Reichel, K.3
  • 151
    • 0017699226 scopus 로고
    • Glucose tolerance and insulin release in hypertensive patients treated with the cardioselective beta-receptor blocking agent metoprolol
    • Ekberg G., Hansson B.G. Glucose tolerance and insulin release in hypertensive patients treated with the cardioselective beta-receptor blocking agent metoprolol. Acta Med Scand 1977, 202:393-397.
    • (1977) Acta Med Scand , vol.202 , pp. 393-397
    • Ekberg, G.1    Hansson, B.G.2
  • 152
    • 0018755838 scopus 로고
    • Differences in metabolic responses to beta-adrenergic stimulation after propranolol or metoprolol administration
    • William-Olsson T., Fellenius E., Bjorntorp P., et al. Differences in metabolic responses to beta-adrenergic stimulation after propranolol or metoprolol administration. Acta Med Scand 1979, 205:201-206.
    • (1979) Acta Med Scand , vol.205 , pp. 201-206
    • William-Olsson, T.1    Fellenius, E.2    Bjorntorp, P.3
  • 153
    • 0035723581 scopus 로고    scopus 로고
    • Beta blocker treatment in diabetes mellitus
    • Sawicki P.T., Siebenhofer A. Beta blocker treatment in diabetes mellitus. J Intern Med 2001, 250:11-17.
    • (2001) J Intern Med , vol.250 , pp. 11-17
    • Sawicki, P.T.1    Siebenhofer, A.2
  • 154
    • 0025012766 scopus 로고
    • Metabolic effects of controlled-release metoprolol in hypertensive men with impaired or diabetic glucose tolerance: a comparison with atenolol
    • Fagerberg B., Berglund A., Holme E., et al. Metabolic effects of controlled-release metoprolol in hypertensive men with impaired or diabetic glucose tolerance: a comparison with atenolol. J Intern Med 1990, 227:37-43.
    • (1990) J Intern Med , vol.227 , pp. 37-43
    • Fagerberg, B.1    Berglund, A.2    Holme, E.3
  • 155
    • 0024598064 scopus 로고
    • Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients
    • Pollare T., Lithell H., Selinus I., et al. Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients. BMJ 1989, 298:1152-1157.
    • (1989) BMJ , vol.298 , pp. 1152-1157
    • Pollare, T.1    Lithell, H.2    Selinus, I.3
  • 156
    • 0028883828 scopus 로고
    • Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland coronary prevention study group
    • Shepherd J., Cobbe S.M., Ford I., et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland coronary prevention study group. N Engl J Med 1995, 333:1301-1307.
    • (1995) N Engl J Med , vol.333 , pp. 1301-1307
    • Shepherd, J.1    Cobbe, S.M.2    Ford, I.3
  • 157
    • 0032487931 scopus 로고    scopus 로고
    • Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
    • The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group
    • The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998, 339:1349-1357.
    • (1998) N Engl J Med , vol.339 , pp. 1349-1357
  • 158
    • 0035804846 scopus 로고    scopus 로고
    • Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial
    • Schwartz G.G., Olsson A.G., Ezekowitz M.D., et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 2001, 285:1711-1718.
    • (2001) JAMA , vol.285 , pp. 1711-1718
    • Schwartz, G.G.1    Olsson, A.G.2    Ezekowitz, M.D.3
  • 159
    • 0033984125 scopus 로고    scopus 로고
    • The evolving role of statins in the management of atherosclerosis
    • Vaughan C.J., Gotto A.M., Basson C.T. The evolving role of statins in the management of atherosclerosis. J Am Coll Cardiol 2000, 35:1-10.
    • (2000) J Am Coll Cardiol , vol.35 , pp. 1-10
    • Vaughan, C.J.1    Gotto, A.M.2    Basson, C.T.3
  • 160
    • 0032584177 scopus 로고    scopus 로고
    • Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors
    • Laufs U., La Fata V., Plutzky J., et al. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 1998, 97:1129-1135.
    • (1998) Circulation , vol.97 , pp. 1129-1135
    • Laufs, U.1    La Fata, V.2    Plutzky, J.3
  • 161
    • 0035830412 scopus 로고    scopus 로고
    • Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance
    • Feron O., Dessy C., Desager J.P., et al. Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance. Circulation 2001, 103:113-118.
    • (2001) Circulation , vol.103 , pp. 113-118
    • Feron, O.1    Dessy, C.2    Desager, J.P.3
  • 162
    • 0035569562 scopus 로고    scopus 로고
    • HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species
    • Wassmann S., Laufs U., Baumer A.T., et al. HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species. Hypertension 2001, 37:1450-1457.
    • (2001) Hypertension , vol.37 , pp. 1450-1457
    • Wassmann, S.1    Laufs, U.2    Baumer, A.T.3
  • 163
    • 0035845530 scopus 로고    scopus 로고
    • Cardiomyocytes induce endothelial cells to trans-differentiate into cardiac muscle: implications for myocardium regeneration
    • Condorelli G., Borello U., De Angelis L., et al. Cardiomyocytes induce endothelial cells to trans-differentiate into cardiac muscle: implications for myocardium regeneration. Proc Natl Acad Sci U S A 2001, 98:10733-10738.
    • (2001) Proc Natl Acad Sci U S A , vol.98 , pp. 10733-10738
    • Condorelli, G.1    Borello, U.2    De Angelis, L.3
  • 164
    • 0035912855 scopus 로고    scopus 로고
    • Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease
    • Vasa M., Fichtlscherer S., Adler K., et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 2001, 103:2885-2890.
    • (2001) Circulation , vol.103 , pp. 2885-2890
    • Vasa, M.1    Fichtlscherer, S.2    Adler, K.3
  • 165
    • 0034899633 scopus 로고    scopus 로고
    • Reduced levels of TNF alpha in hypercholesterolemic individuals after treatment with pravastatin for 8 weeks
    • Solheim S., Seljeflot I., Arnesen H., et al. Reduced levels of TNF alpha in hypercholesterolemic individuals after treatment with pravastatin for 8 weeks. Atherosclerosis 2001, 157:411-415.
    • (2001) Atherosclerosis , vol.157 , pp. 411-415
    • Solheim, S.1    Seljeflot, I.2    Arnesen, H.3
  • 166
    • 0035806626 scopus 로고    scopus 로고
    • Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study
    • Albert M.A., Danielson E., Rifai N., et al. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA 2001, 286:64-70.
    • (2001) JAMA , vol.286 , pp. 64-70
    • Albert, M.A.1    Danielson, E.2    Rifai, N.3
  • 167
    • 11344279659 scopus 로고    scopus 로고
    • C-reactive protein levels and outcomes after statin therapy
    • Ridker P.M., Cannon C.P., Morrow D., et al. C-reactive protein levels and outcomes after statin therapy. N Engl J Med 2005, 352:20-28.
    • (2005) N Engl J Med , vol.352 , pp. 20-28
    • Ridker, P.M.1    Cannon, C.P.2    Morrow, D.3
  • 168
    • 0033529171 scopus 로고    scopus 로고
    • Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase
    • Rao S., Porter D.C., Chen X., et al. Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase. Proc Natl Acad Sci U S A 1999, 96:7797-7802.
    • (1999) Proc Natl Acad Sci U S A , vol.96 , pp. 7797-7802
    • Rao, S.1    Porter, D.C.2    Chen, X.3
  • 169
    • 0029857638 scopus 로고    scopus 로고
    • Protein geranylgeranylation, not farnesylation, is required for the G1 to S phase transition in mouse fibroblasts
    • Vogt A., Qian Y., McGuire T.F., et al. Protein geranylgeranylation, not farnesylation, is required for the G1 to S phase transition in mouse fibroblasts. Oncogene 1996, 13:1991-1999.
    • (1996) Oncogene , vol.13 , pp. 1991-1999
    • Vogt, A.1    Qian, Y.2    McGuire, T.F.3
  • 171
    • 0031747545 scopus 로고    scopus 로고
    • Lovastatin induces apoptosis in malignant mesothelioma cells
    • Rubins J.B., Greatens T., Kratzke R.A., et al. Lovastatin induces apoptosis in malignant mesothelioma cells. Am J Respir Crit Care Med 1998, 157:1616-1622.
    • (1998) Am J Respir Crit Care Med , vol.157 , pp. 1616-1622
    • Rubins, J.B.1    Greatens, T.2    Kratzke, R.A.3
  • 172
    • 36549030340 scopus 로고    scopus 로고
    • Rosuvastatin in older patients with systolic heart failure
    • (Epub ahead of print)
    • Kjekshus J., Apetrei E., Barrios V., et al. Rosuvastatin in older patients with systolic heart failure. N Engl J Med 2007, (Epub ahead of print).
    • (2007) N Engl J Med
    • Kjekshus, J.1    Apetrei, E.2    Barrios, V.3
  • 173
    • 53049095795 scopus 로고    scopus 로고
    • Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
    • Investigators GISSI-HF
    • Investigators GISSI-HF, Tavazzi L., Maggioni A.P., et al. Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 2008, 372:1231-1239.
    • (2008) Lancet , vol.372 , pp. 1231-1239
    • Tavazzi, L.1    Maggioni, A.P.2
  • 174
    • 0034606969 scopus 로고    scopus 로고
    • ABC of heart failure. Non-drug management
    • Gibbs C.R., Jackson G., Lip G.Y. ABC of heart failure. Non-drug management. BMJ 2000, 320:366-369.
    • (2000) BMJ , vol.320 , pp. 366-369
    • Gibbs, C.R.1    Jackson, G.2    Lip, G.Y.3
  • 175
    • 34948814651 scopus 로고    scopus 로고
    • Altered intestinal function in patients with chronic heart failure
    • Sandek A., Bauditz J., Swidsinski A., et al. Altered intestinal function in patients with chronic heart failure. J Am Coll Cardiol 2007, 50:1561-1569.
    • (2007) J Am Coll Cardiol , vol.50 , pp. 1561-1569
    • Sandek, A.1    Bauditz, J.2    Swidsinski, A.3
  • 177
    • 0029026199 scopus 로고
    • Improved left ventricular function after thiamine supplementation in patients with congestive heart failure receiving long-term furosemide therapy
    • Shimon I., Almog S., Vered Z., et al. Improved left ventricular function after thiamine supplementation in patients with congestive heart failure receiving long-term furosemide therapy. Am J Med 1995, 98:485-490.
    • (1995) Am J Med , vol.98 , pp. 485-490
    • Shimon, I.1    Almog, S.2    Vered, Z.3
  • 178
    • 0035202618 scopus 로고    scopus 로고
    • Dietary and blood antioxidants in patients with chronic heart failure. Insights into the potential importance of selenium in heart failure
    • de Lorgeril M., Salen P., Accominotti M., et al. Dietary and blood antioxidants in patients with chronic heart failure. Insights into the potential importance of selenium in heart failure. Eur J Heart Fail 2001, 3:661-669.
    • (2001) Eur J Heart Fail , vol.3 , pp. 661-669
    • de Lorgeril, M.1    Salen, P.2    Accominotti, M.3
  • 179
    • 27544498373 scopus 로고    scopus 로고
    • The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure
    • Witte K.K., Nikitin N.P., Parker A.C., et al. The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure. Eur Heart J 2005, 26:2238-2244.
    • (2005) Eur Heart J , vol.26 , pp. 2238-2244
    • Witte, K.K.1    Nikitin, N.P.2    Parker, A.C.3
  • 180
    • 0036345410 scopus 로고    scopus 로고
    • Nutritional abnormalities contributing to cachexia in chronic illness
    • Witte K.K., Clark A.L. Nutritional abnormalities contributing to cachexia in chronic illness. Int J Cardiol 2002, 85:23-31.
    • (2002) Int J Cardiol , vol.85 , pp. 23-31
    • Witte, K.K.1    Clark, A.L.2
  • 181
    • 33748640122 scopus 로고    scopus 로고
    • Nutritional recommendations for patients with heart failure
    • Lennie T.A. Nutritional recommendations for patients with heart failure. J Cardiovasc Nurs 2006, 21:261-268.
    • (2006) J Cardiovasc Nurs , vol.21 , pp. 261-268
    • Lennie, T.A.1
  • 182
    • 0035091918 scopus 로고    scopus 로고
    • Plasma glutamine depletion and patient outcome in acute ICU admissions
    • Oudemans-van Straaten H.M., Bosman R.J., Treskes M., et al. Plasma glutamine depletion and patient outcome in acute ICU admissions. Intensive Care Med 2001, 27:84-90.
    • (2001) Intensive Care Med , vol.27 , pp. 84-90
    • Oudemans-van Straaten, H.M.1    Bosman, R.J.2    Treskes, M.3
  • 183
    • 0027767533 scopus 로고
    • Plasma amino acid levels in patients with chronic obstructive pulmonary disease
    • Schols A.M., Deutz N.E., Mostert R., et al. Plasma amino acid levels in patients with chronic obstructive pulmonary disease. Monaldi Arch Chest Dis 1993, 48:546-548.
    • (1993) Monaldi Arch Chest Dis , vol.48 , pp. 546-548
    • Schols, A.M.1    Deutz, N.E.2    Mostert, R.3
  • 184
    • 0036227772 scopus 로고    scopus 로고
    • Reversal of cancer-related wasting using oral supplementation with a combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine
    • May P.E., Barber A., D'Olimpio J.T., et al. Reversal of cancer-related wasting using oral supplementation with a combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine. Am J Surg 2002, 183:471-479.
    • (2002) Am J Surg , vol.183 , pp. 471-479
    • May, P.E.1    Barber, A.2    D'Olimpio, J.T.3
  • 185
    • 20844433205 scopus 로고    scopus 로고
    • Branched-chain amino acids: the best compromise to achieve anabolism?
    • Laviano A., Muscaritoli M., Cascino A., et al. Branched-chain amino acids: the best compromise to achieve anabolism?. Curr Opin Clin Nutr Metab Care 2005, 8:408-414.
    • (2005) Curr Opin Clin Nutr Metab Care , vol.8 , pp. 408-414
    • Laviano, A.1    Muscaritoli, M.2    Cascino, A.3
  • 186
    • 0016824053 scopus 로고
    • Leucine. A possible regulator of protein turnover in muscle
    • Buse M.G., Reid S.S. Leucine. A possible regulator of protein turnover in muscle. J Clin Invest 1975, 56:1250-1261.
    • (1975) J Clin Invest , vol.56 , pp. 1250-1261
    • Buse, M.G.1    Reid, S.S.2
  • 187
    • 3242734851 scopus 로고    scopus 로고
    • Acute negative inotropic effects of homocysteine are mediated via the endothelium
    • Kennedy R.H., Owings R., Shekhawat N., et al. Acute negative inotropic effects of homocysteine are mediated via the endothelium. Am J Physiol Heart Circ Physiol 2004, 287:H812-H817.
    • (2004) Am J Physiol Heart Circ Physiol , vol.287
    • Kennedy, R.H.1    Owings, R.2    Shekhawat, N.3
  • 189
    • 0038649172 scopus 로고    scopus 로고
    • Dietary intake of various nutrients in older patients with congestive heart failure
    • Gorelik O., Almoznino-Sarafian D., Feder I., et al. Dietary intake of various nutrients in older patients with congestive heart failure. Cardiology 2003, 99:177-181.
    • (2003) Cardiology , vol.99 , pp. 177-181
    • Gorelik, O.1    Almoznino-Sarafian, D.2    Feder, I.3
  • 190
    • 0032201477 scopus 로고    scopus 로고
    • Nutritional alterations and the effect of fish oil supplementation in
    • Freeman L.M., Rush J.E., Kehayias J.J., et al. Nutritional alterations and the effect of fish oil supplementation in dogs with heart failure. J Vet Intern Med 1998, 12:440-448.
    • (1998) J Vet Intern Med , vol.12 , pp. 440-448
    • Freeman, L.M.1    Rush, J.E.2    Kehayias, J.J.3
  • 192
    • 0034859981 scopus 로고    scopus 로고
    • Metabolic and nutritional disorders in cardiac cachexia
    • Mustafa I., Leverve X. Metabolic and nutritional disorders in cardiac cachexia. Nutrition 2001, 17:756-760.
    • (2001) Nutrition , vol.17 , pp. 756-760
    • Mustafa, I.1    Leverve, X.2
  • 193
    • 0345479157 scopus 로고    scopus 로고
    • The relationship between cholesterol and survival in patients with chronic heart failure
    • Rauchhaus M., Clark A.L., Doehner W., et al. The relationship between cholesterol and survival in patients with chronic heart failure. J Am Coll Cardiol 2003, 42:1933-1940.
    • (2003) J Am Coll Cardiol , vol.42 , pp. 1933-1940
    • Rauchhaus, M.1    Clark, A.L.2    Doehner, W.3
  • 194
    • 0036694809 scopus 로고    scopus 로고
    • Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure
    • Horwich T.B., Hamilton M.A., Maclellan W.R., et al. Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure. J Card Fail 2002, 8:216-224.
    • (2002) J Card Fail , vol.8 , pp. 216-224
    • Horwich, T.B.1    Hamilton, M.A.2    Maclellan, W.R.3
  • 195
    • 10844250124 scopus 로고    scopus 로고
    • Statins for heart failure: at the crossroads between cholesterol reduction and pleiotropism?
    • von Haehling S., Anker S.D. Statins for heart failure: at the crossroads between cholesterol reduction and pleiotropism?. Heart 2005, 91:1-2.
    • (2005) Heart , vol.91 , pp. 1-2
    • von Haehling, S.1    Anker, S.D.2
  • 197
    • 33644673555 scopus 로고    scopus 로고
    • Systematic review of the treatment of cancer-associated anorexia and weight loss
    • Yavuzsen T., Davis M.P., Walsh D., et al. Systematic review of the treatment of cancer-associated anorexia and weight loss. J Clin Oncol 2005, 23:8500-8511.
    • (2005) J Clin Oncol , vol.23 , pp. 8500-8511
    • Yavuzsen, T.1    Davis, M.P.2    Walsh, D.3
  • 198
    • 0030872974 scopus 로고    scopus 로고
    • Effect of medroxyprogesterone acetate on the quality of life of the oncologic patient: a multicentric cooperative study
    • Neri B., Garosi V.L., Intini C. Effect of medroxyprogesterone acetate on the quality of life of the oncologic patient: a multicentric cooperative study. Anticancer Drugs 1997, 8:459-465.
    • (1997) Anticancer Drugs , vol.8 , pp. 459-465
    • Neri, B.1    Garosi, V.L.2    Intini, C.3
  • 199
    • 0028033825 scopus 로고
    • Megestrol acetate stimulates food and water intake in the rat: effects on regional hypothalamic neuropeptide Y concentrations
    • McCarthy H.D., Crowder R.E., Dryden S., et al. Megestrol acetate stimulates food and water intake in the rat: effects on regional hypothalamic neuropeptide Y concentrations. Eur J Pharmacol 1994, 265:99-102.
    • (1994) Eur J Pharmacol , vol.265 , pp. 99-102
    • McCarthy, H.D.1    Crowder, R.E.2    Dryden, S.3
  • 200
    • 0035064287 scopus 로고    scopus 로고
    • Managing cancer-related anorexia/cachexia
    • Mantovani G., Macciò A., Massa E., et al. Managing cancer-related anorexia/cachexia. Drugs 2001, 61:499-514.
    • (2001) Drugs , vol.61 , pp. 499-514
    • Mantovani, G.1    Macciò, A.2    Massa, E.3
  • 201
    • 0028978279 scopus 로고
    • 2+ channel current modulation by megestrol acetate via a G-protein alpha s-subunit in rat hypothalamic neurones
    • 2+ channel current modulation by megestrol acetate via a G-protein alpha s-subunit in rat hypothalamic neurones. J Physiol 1995, 487:291-303.
    • (1995) J Physiol , vol.487 , pp. 291-303
    • Costa, A.M.1    Spence, K.T.2    Plata-Salamán, C.R.3
  • 202
    • 0028935579 scopus 로고
    • Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS
    • Beal J.E., Olson R., Laubenstein L., et al. Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. J Pain Symptom Manage 1995, 10:89-97.
    • (1995) J Pain Symptom Manage , vol.10 , pp. 89-97
    • Beal, J.E.1    Olson, R.2    Laubenstein, L.3
  • 203
    • 0028397811 scopus 로고
    • A phase II study of delta-9-tetrahydrocannabinol for appetite stimulation in cancer-associated anorexia
    • Nelson K., Walsh D., Deeter P., et al. A phase II study of delta-9-tetrahydrocannabinol for appetite stimulation in cancer-associated anorexia. J Palliat Care 1994, 10:14-18.
    • (1994) J Palliat Care , vol.10 , pp. 14-18
    • Nelson, K.1    Walsh, D.2    Deeter, P.3
  • 204
    • 33746793870 scopus 로고    scopus 로고
    • Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the cannabis-in-cachexia-study-group
    • Strasser F., Luftner D., Possinger K., et al. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the cannabis-in-cachexia-study-group. J Clin Oncol 2006, 24:3394-3400.
    • (2006) J Clin Oncol , vol.24 , pp. 3394-3400
    • Strasser, F.1    Luftner, D.2    Possinger, K.3
  • 205
    • 60949092731 scopus 로고    scopus 로고
    • Appetite stimulants
    • Taylor & Francis, Boca Raton, Fla, K.G. Hofbauer, S.D. Anker, A. Inui (Eds.)
    • John M. Appetite stimulants. Pharmacotherapy of cachexia 2006, Taylor & Francis, Boca Raton, Fla. K.G. Hofbauer, S.D. Anker, A. Inui (Eds.).
    • (2006) Pharmacotherapy of cachexia
    • John, M.1
  • 206
    • 28944442442 scopus 로고    scopus 로고
    • Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial
    • Malkin C.J., Pugh P.J., West J.N., et al. Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial. Eur Heart J 2006, 27:57-64.
    • (2006) Eur Heart J , vol.27 , pp. 57-64
    • Malkin, C.J.1    Pugh, P.J.2    West, J.N.3
  • 207
    • 0037991446 scopus 로고    scopus 로고
    • Acute haemodynamic effects of testosterone in men with chronic heart failure
    • Pugh P.J., Jones T.H., Channer K.S. Acute haemodynamic effects of testosterone in men with chronic heart failure. Eur Heart J 2003, 24:909-915.
    • (2003) Eur Heart J , vol.24 , pp. 909-915
    • Pugh, P.J.1    Jones, T.H.2    Channer, K.S.3
  • 208
    • 13844319704 scopus 로고    scopus 로고
    • Treatment with nandrolone decanoate and megestrol acetate in HIV-infected men
    • Cuerda C., Zugasti A., Bretón I., et al. Treatment with nandrolone decanoate and megestrol acetate in HIV-infected men. Nutr Clin Pract 2005, 20:93-97.
    • (2005) Nutr Clin Pract , vol.20 , pp. 93-97
    • Cuerda, C.1    Zugasti, A.2    Bretón, I.3
  • 209
    • 0036036456 scopus 로고    scopus 로고
    • Reversal of COPD-associated weight loss using the anabolic agent oxandrolone
    • Yeh S.S., DeGuzman B., Kramer T. Reversal of COPD-associated weight loss using the anabolic agent oxandrolone. Chest 2002, 122:421-428.
    • (2002) Chest , vol.122 , pp. 421-428
    • Yeh, S.S.1    DeGuzman, B.2    Kramer, T.3
  • 210
    • 15544381195 scopus 로고    scopus 로고
    • Future prospects of anticytokine therapy in chronic heart failure
    • von Haehling S., Anker S.D. Future prospects of anticytokine therapy in chronic heart failure. Expert Opin Investig Drugs 2005, 14:163-176.
    • (2005) Expert Opin Investig Drugs , vol.14 , pp. 163-176
    • von Haehling, S.1    Anker, S.D.2
  • 211
    • 11144355760 scopus 로고    scopus 로고
    • Targeted anticytokine therapy in patients with chronic heart failure: results of the randomized etanercept worldwide evaluation (RENEWAL)
    • Mann D.L., McMurray J.J., Packer M., et al. Targeted anticytokine therapy in patients with chronic heart failure: results of the randomized etanercept worldwide evaluation (RENEWAL). Circulation 2004, 109:1594-1602.
    • (2004) Circulation , vol.109 , pp. 1594-1602
    • Mann, D.L.1    McMurray, J.J.2    Packer, M.3
  • 212
    • 0038755661 scopus 로고    scopus 로고
    • Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF therapy against congestive heart failure (ATTACH) trial
    • Chung E.S., Packer M., Lo K.H., et al. Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF therapy against congestive heart failure (ATTACH) trial. Circulation 2003, 107:3133-3140.
    • (2003) Circulation , vol.107 , pp. 3133-3140
    • Chung, E.S.1    Packer, M.2    Lo, K.H.3
  • 213
    • 0029670957 scopus 로고    scopus 로고
    • Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart
    • Torre-Amione G., Kapadia S., Lee J., et al. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation 1996, 93:704-711.
    • (1996) Circulation , vol.93 , pp. 704-711
    • Torre-Amione, G.1    Kapadia, S.2    Lee, J.3
  • 214
    • 33746839212 scopus 로고    scopus 로고
    • Toll-like receptor modulation in cardiovascular disease: a target for intervention?
    • Foldes G., von Haehling S., Anker S.D. Toll-like receptor modulation in cardiovascular disease: a target for intervention?. Expert Opin Investig Drugs 2006, 15:857-871.
    • (2006) Expert Opin Investig Drugs , vol.15 , pp. 857-871
    • Foldes, G.1    von Haehling, S.2    Anker, S.D.3
  • 215
    • 33744814385 scopus 로고    scopus 로고
    • The anti-CD14 antibody IC14 suppresses ex vivo endotoxin stimulated tumor necrosis factor-alpha in patients with chronic heart failure
    • Genth-Zotz S., von Haehling S., Bolger A.P., et al. The anti-CD14 antibody IC14 suppresses ex vivo endotoxin stimulated tumor necrosis factor-alpha in patients with chronic heart failure. Eur J Heart Fail 2006, 8:366-372.
    • (2006) Eur J Heart Fail , vol.8 , pp. 366-372
    • Genth-Zotz, S.1    von Haehling, S.2    Bolger, A.P.3
  • 216
    • 19544394823 scopus 로고    scopus 로고
    • Whole blood endotoxin responsiveness in patients with chronic heart failure: the importance of serum lipoproteins
    • Sharma R., von Haehling S., Rauchhaus M., et al. Whole blood endotoxin responsiveness in patients with chronic heart failure: the importance of serum lipoproteins. Eur J Heart Fail 2005, 7:479-484.
    • (2005) Eur J Heart Fail , vol.7 , pp. 479-484
    • Sharma, R.1    von Haehling, S.2    Rauchhaus, M.3
  • 217
    • 0034626121 scopus 로고    scopus 로고
    • The endotoxin-lipoprotein hypothesis
    • Rauchhaus M., Coats A.J., Anker S.D. The endotoxin-lipoprotein hypothesis. Lancet 2000, 356:930-933.
    • (2000) Lancet , vol.356 , pp. 930-933
    • Rauchhaus, M.1    Coats, A.J.2    Anker, S.D.3
  • 218
    • 0031760365 scopus 로고    scopus 로고
    • Thalidomide revisited: pharmacology and clinical applications
    • Calabrese L., Resztak K. Thalidomide revisited: pharmacology and clinical applications. Expert Opin Investig Drugs 1998, 7:2043-2060.
    • (1998) Expert Opin Investig Drugs , vol.7 , pp. 2043-2060
    • Calabrese, L.1    Resztak, K.2
  • 220
    • 0026080801 scopus 로고
    • Thalidomide selectively inhibits tumor necrosis factor production by stimulated human monocytes
    • Sampaio E.P., Sarno E.N., Galilly R., et al. Thalidomide selectively inhibits tumor necrosis factor production by stimulated human monocytes. J Exp Med 1991, 173:699-703.
    • (1991) J Exp Med , vol.173 , pp. 699-703
    • Sampaio, E.P.1    Sarno, E.N.2    Galilly, R.3
  • 221
    • 0033532557 scopus 로고    scopus 로고
    • Amino-substituted thalidomide analogs: potent inhibitors of TNF-alpha production
    • Muller G.W., Chen R., Huang S.Y., et al. Amino-substituted thalidomide analogs: potent inhibitors of TNF-alpha production. Bioorg Med Chem Lett 1999, 9:1625-1630.
    • (1999) Bioorg Med Chem Lett , vol.9 , pp. 1625-1630
    • Muller, G.W.1    Chen, R.2    Huang, S.Y.3
  • 222
    • 0034102991 scopus 로고    scopus 로고
    • New therapies for heart failure: is thalidomide the answer?
    • Davey P.P., Ashrafian H. New therapies for heart failure: is thalidomide the answer?. QJM 2000, 93:305-311.
    • (2000) QJM , vol.93 , pp. 305-311
    • Davey, P.P.1    Ashrafian, H.2
  • 223
    • 0036849035 scopus 로고    scopus 로고
    • Effect of thalidomide in patients with chronic heart failure
    • Gullestad L., Semb A.G., Holt E., et al. Effect of thalidomide in patients with chronic heart failure. Am Heart J 2002, 144:847-850.
    • (2002) Am Heart J , vol.144 , pp. 847-850
    • Gullestad, L.1    Semb, A.G.2    Holt, E.3
  • 224
    • 0036774209 scopus 로고    scopus 로고
    • Preclinical and clinical assessment of the safety and potential efficacy of thalidomide in heart failure
    • Agoston I., Dibbs Z.I., Wang F., et al. Preclinical and clinical assessment of the safety and potential efficacy of thalidomide in heart failure. J Card Fail 2002, 8:306-314.
    • (2002) J Card Fail , vol.8 , pp. 306-314
    • Agoston, I.1    Dibbs, Z.I.2    Wang, F.3
  • 225
    • 33644876159 scopus 로고    scopus 로고
    • Effect of thalidomide on cardiac remodeling in chronic heart failure: results of a double-blind, placebo-controlled study
    • Gullestad L., Ueland T., Fjeld J.G., et al. Effect of thalidomide on cardiac remodeling in chronic heart failure: results of a double-blind, placebo-controlled study. Circulation 2005, 112:3408-3414.
    • (2005) Circulation , vol.112 , pp. 3408-3414
    • Gullestad, L.1    Ueland, T.2    Fjeld, J.G.3
  • 227
    • 0036051233 scopus 로고    scopus 로고
    • Cachexia: a therapeutic approach beyond cytokine antagonism
    • von Haehling S., Genth-Zotz S., Anker S.D., et al. Cachexia: a therapeutic approach beyond cytokine antagonism. Int J Cardiol 2002, 85:173-183.
    • (2002) Int J Cardiol , vol.85 , pp. 173-183
    • von Haehling, S.1    Genth-Zotz, S.2    Anker, S.D.3
  • 228
    • 0026046962 scopus 로고
    • Effects of pentoxifylline in endotoxinemia in human volunteers
    • Zabel P., Schonharting M.M., Schade U.F., et al. Effects of pentoxifylline in endotoxinemia in human volunteers. Prog Clin Biol Res 1991, 367:207-213.
    • (1991) Prog Clin Biol Res , vol.367 , pp. 207-213
    • Zabel, P.1    Schonharting, M.M.2    Schade, U.F.3
  • 229
    • 0032507428 scopus 로고    scopus 로고
    • Randomised investigation of effects of pentoxifylline on left-ventricular performance in idiopathic dilated cardiomyopathy
    • Sliwa K., Skudicky D., Candy G., et al. Randomised investigation of effects of pentoxifylline on left-ventricular performance in idiopathic dilated cardiomyopathy. Lancet 1998, 351:1091-1093.
    • (1998) Lancet , vol.351 , pp. 1091-1093
    • Sliwa, K.1    Skudicky, D.2    Candy, G.3
  • 230
    • 1242314227 scopus 로고    scopus 로고
    • Therapy of ischemic cardiomyopathy with the immunomodulating agent pentoxifylline: results of a randomized study
    • Sliwa K., Woodiwiss A., Kone V.N., et al. Therapy of ischemic cardiomyopathy with the immunomodulating agent pentoxifylline: results of a randomized study. Circulation 2004, 109:750-755.
    • (2004) Circulation , vol.109 , pp. 750-755
    • Sliwa, K.1    Woodiwiss, A.2    Kone, V.N.3
  • 231
    • 0035957035 scopus 로고    scopus 로고
    • Beneficial effects of pentoxifylline in patients with idiopathic dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitors and carvedilol: results of a randomized study
    • Skudicky D., Bergemann A., Sliwa K., et al. Beneficial effects of pentoxifylline in patients with idiopathic dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitors and carvedilol: results of a randomized study. Circulation 2001, 103:1083-1088.
    • (2001) Circulation , vol.103 , pp. 1083-1088
    • Skudicky, D.1    Bergemann, A.2    Sliwa, K.3
  • 232
    • 1342324113 scopus 로고    scopus 로고
    • Pentoxifylline in ischemic, hypertensive and idiopathic-dilated cardiomyopathy: effects on left-ventricular function, inflammatory cytokines and symptoms
    • Bahrmann P., Hengst U.M., Richartz B.M., et al. Pentoxifylline in ischemic, hypertensive and idiopathic-dilated cardiomyopathy: effects on left-ventricular function, inflammatory cytokines and symptoms. Eur J Heart Fail 2004, 6:195-201.
    • (2004) Eur J Heart Fail , vol.6 , pp. 195-201
    • Bahrmann, P.1    Hengst, U.M.2    Richartz, B.M.3
  • 234
    • 0028787659 scopus 로고
    • Pentoxifylline for treatment of cancer anorexia and cachexia? A randomized, double-blind, placebo-controlled trial
    • Goldberg R.M., Loprinzi C.L., Mailliard J.A., et al. Pentoxifylline for treatment of cancer anorexia and cachexia? A randomized, double-blind, placebo-controlled trial. J Clin Oncol 1995, 13:2856-2859.
    • (1995) J Clin Oncol , vol.13 , pp. 2856-2859
    • Goldberg, R.M.1    Loprinzi, C.L.2    Mailliard, J.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.